ERAS路径对卵巢癌开腹术后麻醉药品使用的影响
该回顾性队列研究比较了ERAS实施前(2014年)与实施后(2016/2018年)卵巢癌开腹手术患者的术后麻醉药品使用。结果显示ERAS组住院更短、出院前24小时及出院时处方麻醉药品更少,术后三个月内额外处方比例更低,总麻醉药品量减少55%。
要点
- ERAS组住院时间6.7天 vs 4.2天(p=0.003),出院前24小时麻醉药品用量74.0 MME vs 25.8 MME(p=0.002)。
- ERAS组出院时处方麻醉药品519.9 MME vs 339.7 MME(p=0.011),出院后额外处方比例52.4% vs 29.4%(p=0.012)。
- 术后三个月内ERAS组总麻醉药品处方量1101.4 MME vs 492.1 MME(p<0.001),减少55%。
核心结论
- 实施ERAS方案似乎可降低卵巢癌手术后三个月内患者的麻醉药品需求。
研究设计与样本
- 回顾性队列研究,纳入2014年ERAS前42例和2016/2018年ERAS后94例卵巢癌开腹手术患者,排除长期使用麻醉药品者。
主要发现
- ERAS组住院时间6.7天 vs 4.2天(p=0.003)。
- ERAS组出院前24小时麻醉药品用量74.0 MME vs 25.8 MME(p=0.002)。
- ERAS组出院时处方麻醉药品519.9 MME vs 339.7 MME(p=0.011)。
- ERAS组出院后额外处方比例52.4% vs 29.4%(p=0.012)。
- ERAS组术后三个月内总麻醉药品处方量1101.4 MME vs 492.1 MME(p<0.001),减少55%。
临床怎么用
- 在卵巢癌开腹手术患者中实施ERAS路径可能有助于减少术后三个月内的麻醉药品使用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the impact of an ERAS pathway on post-discharge narcotic use for patients with ovarian cancer undergoing open surgery. METHODS: This was a retrospective cohort study of women who underwent open ovarian cancer surgeries in 2014 prior to ERAS ("pre-ERAS") and in 2016/2018 after ERAS was instituted ("ERAS"). Patients taking chronic narcotics were excluded. A statewide prescription monitoring program was used to identify narcotic prescriptions filled in the three months after surgery. Quantity of narcotic medication is referenced in morphine milligram equivalents (MME). RESULTS: 42 pre-ERAS and 94 ERAS patients were included. The groups were similar in age, BMI, diabetes, tobacco use, mean number of prior abdominal/pelvic surgeries, and advanced stage disease. ERAS patients had a shorter hospital stay (6.7 days pre-ERAS vs 4.2 days ERAS, p = 0.003), used less narcotic in the 24 h prior to discharge (74.0 MME pre-ERAS vs 25.8 MME ERAS, p = 0.002), and filled prescriptions at time of discharge for less narcotic (519.9 MME pre-ERAS vs 339.7 MME ERAS, p = 0.011). After hospital discharge, ERAS patients filled fewer additional prescriptions (52.4% pre-ERAS, vs 29.4% ERAS, p = 0.012). In total, ERAS patients filled prescriptions for 55% fewer narcotics in the three months after surgery than the pre-ERAS group (1101.4 MME pre-ERAS vs 492.1 MME ERAS, p < 0.001). CONCLUSIONS: Institution of an ERAS protocol appears to decrease the narcotic needs of patients in the three months after ovarian cancer surgery.
引用
- Kay AH, Venn M, Urban R, et al. Postoperative narcotic use in patients with ovarian cancer on an Enhanced Recovery After Surgery (ERAS) pathway. Gynecol Oncol. 2019. PMID: 31882241. doi:10.1016/j.ygyno.2019.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。